{"Title": "Recent, non-classical, approaches to antibody lysine modification", "Year": 2018, "Source": "Drug Discov. Today Techn.", "Volume": "30", "Issue": null, "Art.No": null, "PageStart": 21, "PageEnd": 26, "CitedBy": 1, "DOI": "10.1016/j.ddtec.2018.09.002", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053889421&origin=inward", "Abstract": "\u00a9 2018 Elsevier LtdThis review will discuss recent development in the bioconjugation of lysine residues on antibodies. As several chemoselective reagents have already been developed for modifying amine groups, recent strategies now tend to aim at being site-specific. Four general methods have been listed: kinetically controlled, template-directed or enzymatic strategies as well as the use of chemically programmed antibodies.", "AuthorKeywords": null, "IndexKeywords": ["Humans", "Immunoconjugates", "Lysine", "Structure-Activity Relationship"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85053889421", "SubjectAreas": [["Molecular Medicine", "BIOC", "1313"], ["Drug Discovery", "PHAR", "3002"]], "AuthorData": {"36719902900": {"Name": "Chaubet G.", "AuthorID": "36719902900", "AffiliationID": "60103368", "AffiliationName": "University of Strasbourg, Faculty of Pharmacy"}, "57193745450": {"Name": "Thoreau F.", "AuthorID": "57193745450", "AffiliationID": "60103368", "AffiliationName": "University of Strasbourg, Faculty of Pharmacy"}, "7401456556": {"Name": "Wagner A.", "AuthorID": "7401456556", "AffiliationID": "60103368", "AffiliationName": "University of Strasbourg, Faculty of Pharmacy"}}}